{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:48:33Z","timestamp":1791805713256,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ebiom.2018.11.066","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T20:07:56Z","timestamp":1545250076000},"page":"226-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0747-5637","authenticated-orcid":false,"given":"Pushpamali","family":"De Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soizic","family":"Garaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Solinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"de Wind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Van den Eyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-8337","authenticated-orcid":false,"given":"Vinu","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Gu-Trantien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2804-1552","authenticated-orcid":false,"given":"Edoardo","family":"Migliori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Boisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Naveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Duvillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia","family":"Craciun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Larsimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Piccart-Gebhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-1295","authenticated-orcid":false,"given":"Karen","family":"Willard-Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6230","key":"10.1016\/j.ebiom.2018.11.066_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"7403","key":"10.1016\/j.ebiom.2018.11.066_bb0010","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2018.11.066_bb0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ebiom.2018.11.066_bb0020","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1257452","article-title":"Tumor-infiltrating lymphocyte composition, organization and PD-1\/ PD-L1 expression are linked in breast cancer","volume":"6","author":"Buisseret","year":"2017","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.ebiom.2018.11.066_bb0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention","volume":"7","author":"Sautes-Fridman","year":"2016","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2018.11.066_bb0030","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2018.11.066_bb0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/icb.2014.110","article-title":"IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media","volume":"93","author":"Pimenta","year":"2015","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2018.11.066_bb0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/icb.2015.39","article-title":"IRF5: a rheostat for tumor-infiltrating lymphocyte trafficking in breast cancer?","volume":"93","author":"Garaud","year":"2015","journal-title":"Immunol Cell Biol"},{"issue":"7","key":"10.1016\/j.ebiom.2018.11.066_bb0045","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI67428","article-title":"Wind Ad, et al. CD4+ follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/jci.insight.91487","article-title":"CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer","volume":"2","author":"Gu-Trantien","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.ebiom.2018.11.066_bb0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.resinv.2012.07.002","article-title":"Analysis of gene expression profiles in alveolar epithelial type II-like cells differentiated from human alveolar epithelial progenitor cells","volume":"50","author":"Fujino","year":"2012","journal-title":"Respir Investig"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0060","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ni1358","article-title":"Foxp1 is an essential transcriptional regulator of B cell development","volume":"7","author":"Hu","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0065","unstructured":"Garaud S, Roufosse F, Silva PD, Gu-Trantien C, Lodewyckx J-N, Duvillier H, et al. Foxp1 is a key regulator of quiescence in healthy human CD3+CD4+ T-cells and constituatively repressed in CD3-CD4+ T-cells from patients with lymphoproliferative disorders. Manuscript in revision."},{"issue":"12","key":"10.1016\/j.ebiom.2018.11.066_bb0070","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood-2008-01-137018","article-title":"Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ebiom.2018.11.066_bb0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/leu.2015.299","article-title":"FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas","volume":"30","author":"Brown","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0080","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.humpath.2011.10.013","article-title":"Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified","volume":"43","author":"Yamada","year":"2012","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.ebiom.2018.11.066_bb0085","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.18632\/oncotarget.6510","article-title":"FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells","volume":"7","author":"Choi","year":"2016","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.ebiom.2018.11.066_bb0090","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/onc.2011.423","article-title":"Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504\/FOXP1 signalling","volume":"31","author":"Yang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0095","first-page":"9","article-title":"Downregulation of FOXP1 inhibits cell proliferation in hepatocellular carcinoma by inducing G1\/S phase cell cycle arrest","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ebiom.2018.11.066_bb0100","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/0008-5472.CAN-13-2117","article-title":"Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity","volume":"74","author":"Gomez","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0105","doi-asserted-by":"crossref","first-page":"30437","DOI":"10.1038\/srep30437","article-title":"Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysis","volume":"6","author":"Xiao","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ebiom.2018.11.066_bb0110","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1158\/1078-0432.CCR-03-0461","article-title":"Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas","volume":"10","author":"Fox","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ebiom.2018.11.066_bb0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10549-007-9812-4","article-title":"Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas","volume":"111","author":"Bates","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.ebiom.2018.11.066_bb0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12672-011-0082-6","article-title":"FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer","volume":"2","author":"Shigekawa","year":"2011","journal-title":"Hormones Cancer"},{"issue":"10","key":"10.1016\/j.ebiom.2018.11.066_bb0125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/jcp.2009.065169","article-title":"Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers","volume":"62","author":"Rayoo","year":"2009","journal-title":"J Clin Pathol"},{"issue":"12","key":"10.1016\/j.ebiom.2018.11.066_bb0130","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1016\/j.celrep.2017.11.096","article-title":"PRMT5 is a critical regulator of breast cancer stem cell function via histone methylation and FOXP1 expression","volume":"21","author":"Chiang","year":"2017","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2018.11.066_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/cbin.10702","article-title":"FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells","volume":"41","author":"Oskay","year":"2017","journal-title":"Cell Biol Int"},{"issue":"e52392","key":"10.1016\/j.ebiom.2018.11.066_bb0140","first-page":"1","article-title":"A simple and rapid protocol to non-enzymatically dissociate fresh human tissues for the analysis of infiltrating lymphocytes","volume":"94","author":"Garaud","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0145","first-page":"8820","article-title":"The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p1","volume":"61","author":"Banham","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.breast.2017.07.005","article-title":"Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: current state of the art","volume":"35","author":"Solinas","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0155","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3389\/fimmu.2017.01412","article-title":"Immune checkpoint molecules on tumor-infiltrating lymphocytes and their association with tertiary lymphoid structures in human breast cancer","volume":"8","author":"Solinas","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2018.11.066_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13058-018-0942-x","article-title":"Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population","volume":"20","author":"Schmidt","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2018.11.066_bb0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13000-018-0715-y","article-title":"Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer","volume":"13","author":"Yu","year":"2018","journal-title":"Diagn Pathol"},{"issue":"12","key":"10.1016\/j.ebiom.2018.11.066_bb0170","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1210\/me.2014-1171","article-title":"Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer","volume":"28","author":"Takayama","year":"2014","journal-title":"Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.ebiom.2018.11.066_bb0175","doi-asserted-by":"crossref","first-page":"612","DOI":"10.5858\/arpa.2014-0122-RA","article-title":"A targetable androgen receptor-positive breast cancer subtype hidden among the triple-negative cancers","volume":"139","author":"Safarpour","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.ebiom.2018.11.066_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PloS one."},{"issue":"24","key":"10.1016\/j.ebiom.2018.11.066_bb0185","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1242\/dev.112672","article-title":"Fox transcription factors: from development to disease","volume":"143","author":"Golson","year":"2016","journal-title":"Development"},{"issue":"14","key":"10.1016\/j.ebiom.2018.11.066_bb0190","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/hmg\/dds132","article-title":"Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease","volume":"21","author":"Tang","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.ebiom.2018.11.066_bb0195","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1034\/j.1600-0463.2002.1101201.x","article-title":"Suppressors of cytokine signalling: SOCS","volume":"110","author":"Larsen","year":"2002","journal-title":"APMIS"},{"issue":"1","key":"10.1016\/j.ebiom.2018.11.066_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.1203103","article-title":"MyD88: a critical adaptor protein in innate immunity signal transduction","volume":"190","author":"Warner","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2018.11.066_bb0205","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00428-011-1143-5","article-title":"Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients","volume":"459","author":"Kim","year":"2011","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2009.23.7370","article-title":"Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer","volume":"28","author":"Denkert","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2018.11.066_bb0220","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1038\/s41598-018-23099-7","article-title":"Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer","volume":"8","author":"Araujo","year":"2018","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.ebiom.2018.11.066_bb0225","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","article-title":"Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer","volume":"71","author":"de Chaisemartin","year":"2011","journal-title":"Cancer Res"},{"issue":"7669","key":"10.1016\/j.ebiom.2018.11.066_bb0230","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.11.066_bb0235","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.immuni.2014.08.012","article-title":"Transforming growth factor b-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression","volume":"41","author":"Stephen","year":"2014","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.ebiom.2018.11.066_bb0240","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1158\/0008-5472.CAN-06-3424","article-title":"High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer","volume":"67","author":"Hojo","year":"2007","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.ebiom.2018.11.066_bb0245","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.5980\/jpnjurol1989.85.1649","article-title":"Production of a lymphocyte chemotactic factor by human renal cancer cells","volume":"85","author":"Muraki","year":"1994","journal-title":"Jpn J Urol"},{"issue":"12","key":"10.1016\/j.ebiom.2018.11.066_bb0250","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1248015","article-title":"Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics","volume":"5","author":"Espinoza","year":"2016","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.ebiom.2018.11.066_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057911","article-title":"Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker","volume":"8","author":"Rachidi","year":"2013","journal-title":"PloS One"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418305711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418305711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T11:46:14Z","timestamp":1551786374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418305711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":51,"alternative-id":["S2352396418305711"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.066","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}